Tekla Healthcare Investors
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 440.5% | – | 453.0% | – | 395.1% | – | 334.0% | 167.0% | 366.7% | 183.4% | 166.6% | 168.2% | 132.9% | 131.6% | 131.4% | 131.4% | 244.5% | 122.2% | 191.3% | – | 268.2% | – | 349.5% | – | 376.6% | – | 287.7% | – | 9.6% | – | 21.8% | – | 7.2% | – | 194.3% | – | – | – | 30.1% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -66.6% | 100.0% | -32.9% | 100.0% | -31.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 90.4% | 100.0% | 78.2% | 100.0% | 92.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 69.9% | |
| – | 0.0% | – | – | – | 0.0% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 357.6% | 236.2% | 236.2% | 248.6% | 248.6% | 214.1% | 214.1% | 183.8% | 183.8% | 200.1% | 200.1% | 11.6% | 181.9% | 7.9% | 144.0% | 8.8% | 143.5% | 132.4% | 132.4% | 104.0% | 104.0% | 145.3% | 145.3% | 188.7% | 188.7% | 203.7% | 203.7% | 156.6% | 156.6% | 5.1% | 133.2% | 11.5% | 102.9% | 3.8% | 121.9% | 100.2% | 100.2% | 102.8% | 102.8% | – | |
| 357.6% | 4,100.1% | 236.2% | 5,183.7% | 248.6% | 2,429.2% | 214.1% | 1,165.8% | 183.8% | 2,958.1% | 200.1% | 15.3% | 181.9% | 11.1% | 144.0% | 11.1% | 143.5% | 1,665.3% | 132.4% | 856.6% | 104.0% | 4,838.0% | 145.3% | 2,612.9% | 188.7% | 1,971.4% | 203.7% | 3,008.4% | 156.6% | 74.5% | 133.2% | 153.8% | 102.9% | 20.9% | 121.9% | 100.6% | 100.6% | 103.5% | 103.5% | -948.6% | |
| -257.6% | -272.4% | -136.2% | -296.9% | -148.6% | -228.3% | -114.1% | -167.3% | -83.8% | -200.2% | -100.1% | -81.9% | -81.9% | -44.0% | -44.0% | -42.5% | -43.5% | -64.7% | -32.4% | -7.9% | -4.0% | -45.3% | -45.3% | -88.7% | -88.7% | -103.7% | -103.7% | -2,908.4% | -56.6% | -141.2% | -33.2% | 329.9% | -2.9% | -35.6% | -21.9% | 3,758.4% | -0.6% | -3.5% | -3.5% | 1,018.5% | |
| – | 7,728.2% | – | 9,870.4% | – | 5,286.6% | – | 2,699.4% | 0.0% | 6,316.4% | 0.0% | 2,105.7% | 0.0% | 3,599.2% | – | 2,232.1% | – | 3,065.8% | – | 1,921.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12,760.9% | -4,000.1% | -4,000.1% | -5,083.7% | -5,083.7% | 2,529.2% | 2,529.2% | 1,265.8% | 1,265.8% | 3,058.1% | 3,058.1% | -2,187.6% | -2,187.6% | 3,555.2% | 3,555.2% | -2,274.6% | -2,274.6% | -1,565.3% | -1,565.3% | 956.6% | 956.6% | 4,938.0% | 4,938.0% | 2,712.9% | 2,712.9% | 2,071.4% | 2,071.4% | -2,908.4% | -2,908.4% | -141.2% | -1,835.0% | 329.9% | 1,477.7% | -35.7% | -575.2% | 1,879.2% | 1,879.2% | 1,560.2% | 1,560.2% | 1,018.5% | |
| -3,273.9% | 0.0% | -2,111.5% | – | 1,400.7% | 0.0% | 770.5% | – | 1,566.6% | 0.0% | -1,126.7% | 0.0% | 2,277.1% | 0.0% | -1,092.3% | – | -803.7% | – | 619.8% | – | 1,941.2% | 4,983.4% | 1,169.0% | 2,801.6% | 1,071.2% | 2,175.1% | -1,754.1% | -2,851.8% | -982.7% | 0.0% | 965.5% | 0.0% | -229.3% | 0.0% | 1,069.1% | -1.6% | – | – | – | – | |
| 12,760.9% | -4,000.1% | -4,000.1% | -5,083.7% | -5,083.7% | 2,529.2% | 2,529.2% | 1,265.8% | 1,265.8% | 3,058.1% | 3,058.1% | -2,187.6% | -2,187.6% | 3,555.2% | 3,555.2% | -2,274.6% | -2,274.6% | -1,565.3% | -1,565.3% | 956.6% | 956.6% | 4,938.0% | 4,938.0% | 2,712.9% | 2,712.9% | 2,071.4% | 2,071.4% | -2,908.4% | -2,908.4% | -141.2% | -1,835.0% | 329.9% | 1,477.7% | -35.7% | -575.2% | 1,879.2% | 1,879.2% | 1,560.2% | 1,560.2% | 1,018.5% | |
| -3,273.9% | -3,864.0% | -2,111.5% | -4,935.1% | 1,400.7% | 2,643.3% | 770.5% | 1,349.6% | 1,566.6% | 3,158.2% | -1,126.7% | -2,187.6% | 2,277.1% | 7,154.4% | -1,092.3% | -2,274.6% | -803.7% | -1,532.9% | 619.8% | 960.5% | 1,941.2% | 4,983.4% | 1,169.0% | 2,801.6% | 1,071.2% | 2,175.1% | -1,754.1% | -2,851.8% | -982.7% | -141.2% | 965.5% | 329.9% | -229.3% | -35.6% | 1,069.1% | 3,758.4% | – | – | – | 1,018.5% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.